HEADER TRANSFERASE/TRANSFERASE INHIBITOR 02-APR-15 4Z55 TITLE ANAPLASTIC LYMPHOMA KINASE CATALYTIC DOMAIN COMPLEXED WITH TITLE 2 PYRAZOLOPYRIMIDINE DERIVATIVE OF LDK378 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALK TYROSINE KINASE RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 1072-1410; COMPND 5 SYNONYM: ANAPLASTIC LYMPHOMA KINASE; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ALK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS CATALYTIC DOMAIN, TRANSFERASE, INHIBITOR, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.C.LEE,G.SPRAGGON REVDAT 3 06-MAR-24 4Z55 1 JRNL REMARK REVDAT 2 10-FEB-16 4Z55 1 JRNL REVDAT 1 03-FEB-16 4Z55 0 JRNL AUTH P.Y.MICHELLYS,B.CHEN,T.JIANG,Y.JIN,W.LU,T.H.MARSILJE,W.PEI, JRNL AUTH 2 T.UNO,X.ZHU,B.WU,T.N.NGUYEN,B.BURSULAYA,C.LEE,N.LI,S.KIM, JRNL AUTH 3 T.TUNTLAND,B.LIU,F.SUN,A.STEFFY,T.HOOD JRNL TITL DESIGN AND SYNTHESIS OF NOVEL SELECTIVE ANAPLASTIC LYMPHOMA JRNL TITL 2 KINASE INHIBITORS. JRNL REF BIOORG.MED.CHEM.LETT. V. 26 1090 2016 JRNL REFN ESSN 1464-3405 JRNL PMID 26750252 JRNL DOI 10.1016/J.BMCL.2015.11.049 REMARK 2 REMARK 2 RESOLUTION. 1.55 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.55 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.32 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 70.3 REMARK 3 NUMBER OF REFLECTIONS : 32543 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.186 REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.208 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.920 REMARK 3 FREE R VALUE TEST SET COUNT : 1602 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 16 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.55 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.60 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 70.30 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 29 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2020 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 28 REMARK 3 BIN R VALUE (WORKING SET) : 0.2016 REMARK 3 BIN FREE R VALUE : 0.2132 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 3.45 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 1 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2280 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 53 REMARK 3 SOLVENT ATOMS : 197 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.38 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.63 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.04270 REMARK 3 B22 (A**2) : 1.16810 REMARK 3 B33 (A**2) : -1.12530 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.191 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.113 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.104 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.108 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.101 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.945 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.928 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2430 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3308 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 831 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 53 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 357 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2430 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 311 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : 8 ; 1.000 ; HARMONIC REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3018 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 0.99 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.13 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.08 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4Z55 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-APR-15. REMARK 100 THE DEPOSITION ID IS D_1000208587. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-JUN-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9765 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 45757 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.550 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 4.200 REMARK 200 R MERGE (I) : 0.06300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.55 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.58 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.9 REMARK 200 DATA REDUNDANCY IN SHELL : 2.70 REMARK 200 R MERGE FOR SHELL (I) : 0.97000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: BUSTER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.83 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.04 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CITRIC ACID, BIS-TRIS PROPANE, REMARK 280 PEG3350, PH 7.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.78000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 52.71000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.76000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 52.71000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.78000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 28.76000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 510 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13230 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 1072 REMARK 465 LEU A 1073 REMARK 465 GLN A 1074 REMARK 465 SER A 1075 REMARK 465 PRO A 1076 REMARK 465 GLU A 1077 REMARK 465 TYR A 1078 REMARK 465 LYS A 1079 REMARK 465 LEU A 1080 REMARK 465 SER A 1081 REMARK 465 LYS A 1082 REMARK 465 LEU A 1083 REMARK 465 ARG A 1084 REMARK 465 THR A 1085 REMARK 465 SER A 1086 REMARK 465 THR A 1087 REMARK 465 ILE A 1088 REMARK 465 MET A 1089 REMARK 465 THR A 1090 REMARK 465 ASP A 1091 REMARK 465 TYR A 1092 REMARK 465 GLY A 1137 REMARK 465 MET A 1138 REMARK 465 PRO A 1139 REMARK 465 ASN A 1140 REMARK 465 ASP A 1141 REMARK 465 PRO A 1142 REMARK 465 SER A 1143 REMARK 465 SER A 1216 REMARK 465 GLN A 1217 REMARK 465 PRO A 1218 REMARK 465 SER A 1219 REMARK 465 SER A 1220 REMARK 465 ARG A 1284 REMARK 465 GLU A 1400 REMARK 465 TYR A 1401 REMARK 465 GLY A 1402 REMARK 465 PRO A 1403 REMARK 465 LEU A 1404 REMARK 465 VAL A 1405 REMARK 465 GLU A 1406 REMARK 465 GLU A 1407 REMARK 465 GLU A 1408 REMARK 465 GLU A 1409 REMARK 465 LYS A 1410 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A1093 CG OD1 ND2 REMARK 470 LYS A1101 CD CE NZ REMARK 470 GLU A1129 CG CD OE1 OE2 REMARK 470 GLU A1158 CG CD OE1 OE2 REMARK 470 ARG A1209 NE CZ NH1 NH2 REMARK 470 ARG A1214 CG CD NE CZ NH1 NH2 REMARK 470 TYR A1282 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS A1285 CE NZ REMARK 470 LYS A1352 CE NZ REMARK 470 GLU A1384 CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A1248 -11.13 76.59 REMARK 500 ASP A1249 43.99 -143.80 REMARK 500 SER A1332 -1.12 73.73 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 1501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 1502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4LO A 1503 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3L9P RELATED DB: PDB REMARK 900 SAME PROTEIN IN APO FORM REMARK 900 RELATED ID: 4MKC RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH LDK378 REMARK 900 RELATED ID: 3LCS RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH STAUROSPORIN REMARK 900 RELATED ID: 3LCT RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH ADP DBREF 4Z55 A 1072 1410 UNP Q9UM73 ALK_HUMAN 1072 1410 SEQADV 4Z55 GLY A 1281 UNP Q9UM73 SER 1281 ENGINEERED MUTATION SEQRES 1 A 339 GLU LEU GLN SER PRO GLU TYR LYS LEU SER LYS LEU ARG SEQRES 2 A 339 THR SER THR ILE MET THR ASP TYR ASN PRO ASN TYR CYS SEQRES 3 A 339 PHE ALA GLY LYS THR SER SER ILE SER ASP LEU LYS GLU SEQRES 4 A 339 VAL PRO ARG LYS ASN ILE THR LEU ILE ARG GLY LEU GLY SEQRES 5 A 339 HIS GLY ALA PHE GLY GLU VAL TYR GLU GLY GLN VAL SER SEQRES 6 A 339 GLY MET PRO ASN ASP PRO SER PRO LEU GLN VAL ALA VAL SEQRES 7 A 339 LYS THR LEU PRO GLU VAL CYS SER GLU GLN ASP GLU LEU SEQRES 8 A 339 ASP PHE LEU MET GLU ALA LEU ILE ILE SER LYS PHE ASN SEQRES 9 A 339 HIS GLN ASN ILE VAL ARG CYS ILE GLY VAL SER LEU GLN SEQRES 10 A 339 SER LEU PRO ARG PHE ILE LEU LEU GLU LEU MET ALA GLY SEQRES 11 A 339 GLY ASP LEU LYS SER PHE LEU ARG GLU THR ARG PRO ARG SEQRES 12 A 339 PRO SER GLN PRO SER SER LEU ALA MET LEU ASP LEU LEU SEQRES 13 A 339 HIS VAL ALA ARG ASP ILE ALA CYS GLY CYS GLN TYR LEU SEQRES 14 A 339 GLU GLU ASN HIS PHE ILE HIS ARG ASP ILE ALA ALA ARG SEQRES 15 A 339 ASN CYS LEU LEU THR CYS PRO GLY PRO GLY ARG VAL ALA SEQRES 16 A 339 LYS ILE GLY ASP PHE GLY MET ALA ARG ASP ILE TYR ARG SEQRES 17 A 339 ALA GLY TYR TYR ARG LYS GLY GLY CYS ALA MET LEU PRO SEQRES 18 A 339 VAL LYS TRP MET PRO PRO GLU ALA PHE MET GLU GLY ILE SEQRES 19 A 339 PHE THR SER LYS THR ASP THR TRP SER PHE GLY VAL LEU SEQRES 20 A 339 LEU TRP GLU ILE PHE SER LEU GLY TYR MET PRO TYR PRO SEQRES 21 A 339 SER LYS SER ASN GLN GLU VAL LEU GLU PHE VAL THR SER SEQRES 22 A 339 GLY GLY ARG MET ASP PRO PRO LYS ASN CYS PRO GLY PRO SEQRES 23 A 339 VAL TYR ARG ILE MET THR GLN CYS TRP GLN HIS GLN PRO SEQRES 24 A 339 GLU ASP ARG PRO ASN PHE ALA ILE ILE LEU GLU ARG ILE SEQRES 25 A 339 GLU TYR CYS THR GLN ASP PRO ASP VAL ILE ASN THR ALA SEQRES 26 A 339 LEU PRO ILE GLU TYR GLY PRO LEU VAL GLU GLU GLU GLU SEQRES 27 A 339 LYS HET GOL A1501 6 HET GOL A1502 6 HET 4LO A1503 41 HETNAM GOL GLYCEROL HETNAM 4LO N~6~-[5-METHYL-4-(1-METHYLPIPERIDIN-4-YL)-2-(PROPAN-2- HETNAM 2 4LO YLOXY)PHENYL]-N~4~-[2-(PROPAN-2-YLSULFONYL)PHENYL]-2H- HETNAM 3 4LO PYRAZOLO[3,4-D]PYRIMIDINE-4,6-DIAMINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 GOL 2(C3 H8 O3) FORMUL 4 4LO C30 H39 N7 O3 S FORMUL 5 HOH *197(H2 O) HELIX 1 AA1 SER A 1104 LEU A 1108 5 5 HELIX 2 AA2 PRO A 1112 LYS A 1114 5 3 HELIX 3 AA3 SER A 1157 PHE A 1174 1 18 HELIX 4 AA4 ASP A 1203 ARG A 1212 1 10 HELIX 5 AA5 ALA A 1222 ASN A 1243 1 22 HELIX 6 AA6 ALA A 1251 ARG A 1253 5 3 HELIX 7 AA7 PHE A 1271 GLY A 1281 1 11 HELIX 8 AA8 GLY A 1287 LEU A 1291 5 5 HELIX 9 AA9 PRO A 1292 MET A 1296 5 5 HELIX 10 AB1 PRO A 1297 GLY A 1304 1 8 HELIX 11 AB2 THR A 1307 SER A 1324 1 18 HELIX 12 AB3 SER A 1334 SER A 1344 1 11 HELIX 13 AB4 PRO A 1355 TRP A 1366 1 12 HELIX 14 AB5 GLN A 1369 ARG A 1373 5 5 HELIX 15 AB6 ASN A 1375 ASP A 1389 1 15 HELIX 16 AB7 ASP A 1389 ASN A 1394 1 6 SHEET 1 AA1 2 TYR A1096 PHE A1098 0 SHEET 2 AA1 2 LYS A1101 SER A1103 -1 O SER A1103 N TYR A1096 SHEET 1 AA2 5 ILE A1116 HIS A1124 0 SHEET 2 AA2 5 GLU A1129 VAL A1135 -1 O VAL A1130 N LEU A1122 SHEET 3 AA2 5 LEU A1145 LEU A1152 -1 O VAL A1149 N TYR A1131 SHEET 4 AA2 5 ARG A1192 GLU A1197 -1 O LEU A1196 N ALA A1148 SHEET 5 AA2 5 CYS A1182 SER A1186 -1 N GLY A1184 O LEU A1195 SHEET 1 AA3 2 CYS A1255 LEU A1257 0 SHEET 2 AA3 2 ALA A1266 ILE A1268 -1 O LYS A1267 N LEU A1256 CISPEP 1 LEU A 1190 PRO A 1191 0 -0.11 SITE 1 AC1 7 HIS A1244 PHE A1245 ILE A1246 ARG A1248 SITE 2 AC1 7 ALA A1274 TYR A1278 HOH A1662 SITE 1 AC2 8 ILE A1171 SER A1172 PHE A1174 ASN A1175 SITE 2 AC2 8 ARG A1181 CYS A1182 HOH A1611 HOH A1615 SITE 1 AC3 13 LEU A1122 HIS A1124 GLY A1125 ALA A1148 SITE 2 AC3 13 LYS A1150 LEU A1196 GLU A1197 MET A1199 SITE 3 AC3 13 ALA A1200 ASP A1203 SER A1206 LEU A1256 SITE 4 AC3 13 ASP A1270 CRYST1 51.560 57.520 105.420 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019395 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017385 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009486 0.00000